Showing results (381-390 of 404) with videos related to
Sort By:
Pageof 41
Blood|July 9, 1999
Increased fragmentation of von Willebrand factor, due to abnormal cleavage of the subunit, parallels disease activity in recurrent hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and discloses predisposition in families. The Italian Registry of Familial and Recurrent HUS/TTPM Galbusera, M Noris, C Rossi, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 8, 2006
Favorable long-term outcome after liver-kidney transplant for recurrent hemolytic uremic syndrome associated with a factor H mutationJ M Saland, S H Emre, B L Shneider, et al.Kidney International|June 16, 2006
A classification of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and related disordersN Besbas, D Karpman, D Landau, et al.Kidney International|March 31, 2006
Renal risk and renoprotection among ethnic groups with type 2 diabetic nephropathy: a post hoc analysis of RENAALD de Zeeuw, D Ramjit, Z Zhang, et al.Transplantation|February 7, 2001
Epstein-Barr virus-negative lymphoproliferate disorders in long-term survivors after heart, kidney, and liver transplantG Dotti, R Fiocchi, T Motta, et al.Prostaglandins|July 1, 1980
Reduced umbilical and placental vascular prostacyclin in severe pre-eclampsiaG Remuzzi, D Marchesi, C Zoja, et al.The New England Journal of Medicine|November 26, 1998
von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndromeM Furlan, R Robles, M Galbusera, et al.Journal of the American Society of Nephrology : JASN|May 1, 1997
Renal expression of monocyte chemoattractant protein-1 in lupus autoimmune miceC Zoja, X H Liu, R Donadelli, et al.Ugeskrift for Laeger|October 17, 2001
[Effect of losartan on renal and cardiovascular complications of patients with type 2 diabetes and nephropathy]H H Parving, B M Brenner, M E Cooper, et al.The New England Journal of Medicine|September 22, 2001
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathyB M Brenner, M E Cooper, D de Zeeuw, et al.Pageof 41